preprint cases number epidemic model transmission population time covid license data rate infected copyright medrxiv individuals holder disease author/funder case infection peer-reviewed outbreak https://doi.org infectious doi figure period days contact display granted made international perpetuity spread control estimated china reported distribution estimates measures day susceptible fig total probability parameters countries 
cells immune cell response expression infection mice responses macrophages disease cytokines activation production inflammatory role tlr cns cytokine levels increased human inflammation studies lymphocytes innate receptor type specific shown receptors antigen system dcs immunity important function molecules mechanisms induced mhc activated found cxcl class lung monocytes t-cell development infections expressed 
membrane proteins protein cells cell fusion surface binding membranes receptor lipid entry golgi domain acid formation particles shown vesicles plasma glycoproteins found receptors fig transport cellular glycoprotein complex form envelope acids assembly role intracellular structures transmembrane interaction virions specific amino cytoplasmic sialic pathway glycosylation release studies required cleavage cholesterol domains 
protein proteins expression cells infection signaling ifn activation cell viral pathway response genes cellular replication host autophagy activity pathways gene apoptosis transcription role rna type irf phosphorylation nuclear immune antiviral induction dna isg degradation shown complex levels kinase stat innate induced involved figure production rig-i factor binding stress including function 
blood patients cancer recipients cell tumor donor transplant transplantation donors transfusion work plasma therapy treatment patient cells risk hsct platelet cmv time marrow clinical ebv tumors survival bone received stem months chemotherapy reported rejection testing form hct lymphoma platelets information study recipient gvhd present leukemia screening products antibodies submitted allogeneic 
species disease human transmission humans animals virus animal bats diseases infection host pathogens population wild bat populations risk hosts cases birds infected food areas zoonotic outbreaks infectious reported viruses infections found spread pathogen rabies africa water high contact poultry including wildlife domestic exposure potential studies transmitted years dengue avian fever 
influenza respiratory children study virus viruses rsv viral infection infections patients age years studies detected cases clinical tract samples symptoms illness data hrv positive disease hmpv table found human pneumonia reported acute detection lower pathogens adults severe rhinovirus infants specimens common months hbov identified seasonal year group compared nasal days 
care patients health hospital patient medical infection staff risk control hospitals healthcare workers contact emergency participants transmission study training outbreak measures sars isolation time hand nurses information equipment procedures reported pandemic work infectious exposure covid hygiene management practice hcws facilities students room personnel knowledge personal survey ppe including number protective 
bacteria bacterial resistance strains pathogens infections antimicrobial isolates coli antibiotic infection aureus organisms antibiotics microbial species infl resistant results pathogen strain mrsa pneumoniae spp microorganisms methods culture isolated colonization host uenza aeruginosa susceptibility toxin agents virulence salmonella human found growth microbiota pathogenic gram-negative tuberculosis organism fungal staphylococcus rst genes studies 
sequences genes gene sequence genome analysis genetic sequencing species table genomes human data identified figure viruses reads phylogenetic fig number selection dna amino found nucleotide genomic mutations regions diversity evolution host region acid evolutionary protein variants samples tree based study database analyses codon strains recombination mutation reference related viral sites 
vaccine vaccines antibodies antibody protein immune responses vaccination antigen igg recombinant response dna immunization neutralizing epitopes proteins antigens protection mice human immunity development cells specific cell gene expression delivery epitope vector production vectors immunized mabs virus challenge high protective vaccinated serum efficacy effective sera studies neutralization developed system induce adjuvant 
social people china government economic tourism risk chinese market world public time hong urban international policy industry media crisis change kong development disaster travel growth level effects local research impact years security countries global life state management services sars study important demand political business cities factors air major information city 
cells fig cell protein min expression figure incubated control assay data performed medium pbs results antibody buffer analysis infected shown culture previously added washed observed determined analyzed treated plates experiments activity serum antibodies infection compared usa purified effect concentration showed total western obtained transfected detected study samples incubation levels times 
cells lesions disease tissue fig cell epithelial epithelium small skin present mucosa occur infection necrosis common tissues nasal cases inflammation large occurs include normal chronic affected animals lymph surface species found liver areas form mucosal result inflammatory lesion intestinal similar intestine severe reported type tract macrophages acute lymphocytes characterized nodes 
virus strains pedv strain ibv prrsv gene viruses tgev study pigs samples viral porcine sequence orf group rna isolates detected sequences protein chickens showed infection swine amino acid china type genome analysis rt-pcr pcv piglets isolated pcr table fig coronavirus reported positive chicken infected nucleotide collected birds found observed based 
rna nsp protein sequence mrna viral replication genome translation proteins synthesis gene orf rnas fig virus dna site sequences region structure transcription end sirna mrnas polymerase shown activity figure viruses expression nucleotides genomic vitro codon mhv mutant sites strand frameshifting nucleotide rdrp initiation complex cleavage template mutations products structures conserved 
virus viral viruses infection hiv replication host cells infected cell influenza antiviral human rna hcv infections studies ifitm denv genome infectious hsv hepatitis entry cellular strains treatment zikv particles hbv target dna resistance type ebov disease including proteins important activity early shown immune highly dengue humans development mutations capsid effect 
cats dogs disease signs clinical blood cat treatment horses feline cases diagnosis normal fip fluid common serum examination include animals increased canine therapy small abdominal present mg/kg affected body result dog occur severe hours administration time loss heart foals ferrets chronic pain weeks results days performed fiv felv liver concentrations 
health public disease diseases research countries global surveillance information data national development infectious systems system international response control risk including medical outbreak human states world pandemic care provide community potential management important population resources approach emerging prevention access support include services efforts developing developed clinical local capacity years ebola outbreaks 
activity compounds drug compound acid drugs inhibition inhibitors antiviral effects group treatment showed effect active reported reaction derivatives activities found inhibitory synthesis plant extract concentration inhibitor cell potent table concentrations vitro effective potential inhibit chemical plants action extracts obtained properties groups enzyme mixture fig toxicity inhibited addition agents shown solution 
samples detection pcr assay dna sample positive assays sensitivity rna results test methods amplification method reaction clinical diagnostic negative primers detected detect testing specific target rt-pcr specificity tests nucleic specimens real-time primer performed probe analysis probes molecular diagnosis tested min rapid laboratory table developed acid high control standard time based 
calves animals diarrhea milk cattle disease pigs days infection rotavirus age intestinal calf bovine animal study herds cows fecal feed herd colostrum period production samples control infected farms diarrhoea found dairy weeks high farm clinical neonatal birth piglets feces reported treatment feeding fed bvdv coli studies table serum time infections 
expression cells ace cell levels activity effects human increased mice brain studies receptor role lung tissue protein gene injury liver function ang activation disease treatment effect development increase neurons system rats found growth vivo including cancer factor reduced study mouse model endothelial muscle shown potential rat normal diseases significantly induced 
protein binding residues structure proteins peptide domain peptides fig site amino structural interactions pro structures figure activity sequence complex interaction residue protease domains affinity acid substrate molecular region shown form sites enzyme crystal cleavage active catalytic hydrophobic conformation acids molecules loop similar fusion conserved surface observed c-terminal bound model n-terminal 
data model models number time information network analysis results set based methods method system fig values approach study table process networks i.e parameters function e.g structure figure probability distribution size individual case prediction order section spatial algorithm large performance average test rate nodes terms shown studies proposed dynamics distance defined 
sars-cov sars mers-cov coronavirus virus respiratory infection patients human cases mers viral cov covid coronaviruses ace reported severe transmission outbreak disease spike china rbd camels syndrome infected hcov covs study case confirmed including saudi identified protein showed acute ncov humans rna middle arabia patient positive east clinical found studies hku 
patients infection disease pneumonia treatment clinical respiratory cases acute diagnosis therapy infections lung severe fever symptoms patient children pulmonary days common risk chest blood mortality include chronic syndrome illness failure bacterial early infants cough viral including case high reported caused agents evidence due increased diagnostic present complications cap onset antibiotics 
patients study group studies treatment results data significant asthma age compared clinical risk analysis higher years groups significantly levels included subjects days increased mortality test total showed found score time reported symptoms factors effect hospital severe lower day table performed rate differences patient outcomes median disease control difference level outcome 
mice infection virus day infected animals group days mouse fig lung observed groups control viral figure levels animal mhv compared study serum data tissue titers significant rats significantly inoculation lungs detected strain dpi dose weight model tissues inoculated antibody brain challenge showed results liver time previously disease shown differences blood 
air water particles surface temperature concentration fig high size flow nanoparticles particle system time conditions process due solution rate systems method chemical shown materials low concentrations higher surfaces environment study airborne exposure area pressure filter efficiency ventilation environmental wind studies effect aerosol properties room range light volume material results based 
